Register For UpdatesAbout IC-HEP

Registration

Leave this field empty
Back to links
Back to links

United States Education

Expert Perspectives: Highlights on HCV from EASL 2017

Expert Perspectives: Highlights on HCV from EASL 2017

Jasmohan Bajaj, MD & Rajender Reddy, MD

Endorsed by:

Expert Perspectives: Highlights on HCV from AASLD 2016

Expert Perspectives: Highlights on HCV from AASLD 2016

Nancy Reau, MD & Zobair Younossi, MD

Endorsed by:

AUDIOCAST of the CLDF CME Symposium at UEGW 2016 - Vienna, Austria

Get Ready for the Global Epidemic of NASH: Evolving Diagnosis and Treatment Strategies

Vlad Ratziu, MD, PhD & Zobair M. Younossi, MD, MPH

Supported by Intercept
Pharmaceuticals, Inc.

Expert Perspectives on the Management of PBC: A Case-Based Approach

Cynthia Levy, MD & Gideon M. Hirschfield, MB BChir FRCP PhD

Supported by Intercept
Pharmaceuticals, Inc.

Challenges and Opportunities in the Management of Chronic Hepatitis C

Review of the Treatment of Hepatitis C Genotypes 2-6

David Bernstein, MD & Eugene Schiff, MD

Supported by: Bristol-Myers Squibb & Merck

HCV Resistance

Kimberly Brown, MD & Ira Jacobson, MD

Supported by: Bristol-Myers Squibb & Merck

Advances in Cirrhosis Management

Jasmohan Bajaj, MD & Nancy Reau, MD

Supported by: Bristol-Myers Squibb & Merck

HIV-HCV Coinfection

Fred Poordad, MD & Mark Sulkowski, MD

Supported by: Bristol-Myers Squibb & Merck

Renal Insufficiency

Robert Brown, MD & Paul Kwo, MD

Supported by: Bristol-Myers Squibb & Merck

Update on HCV Guidelines

Steven Flamm, MD & Robert Gish, MD

Supported by: Bristol-Myers Squibb & Merck

Expert Perspectives: Best of HCV - 2016 Spring Update

Expert Perspectives: Best of HCV - 2016 Spring Update

Paul Kwo, MD & Tram Tran, MD

Supported by: AbbVie, Bristol-Myers Squibb, Gilead Sciences, and Merck

2015 Education

LIVER SUMMIT SERIES

LIVER SUMMIT SERIES

Review of the WHO Guidelines for the Screening, Care, and
Treatment of Persons with HCV

Review of the WHO Guidelines for the Screening, Care, and Treatment of Persons with HCV

Raj Reddy, MD

Supported by: AbbVie, Bristol-Myers Squibb, Gilead Sciences, Inc., and Merck

Expert Perspectives: Best of HCV from EASL 2015

Expert Perspectives: Best of HCV from EASL 2015

D. Bernstein & M. Shiffman, USA

Supported by: AbbVie, Bristol-Myers Squibb, Gilead Sciences, and Merck

2014 Education

WGO 2014

  • HCC: A Global Crisis Silent and Widely Ignored Douglas R. LaBrecque, MD Watch Slides

Best of HCV from AASLD 2014

  • Best of HCV from AASLD 2014 Mark Sulkowski, MD Watch Slides
  • Best of HCV from AASLD 2014 Kris Kowdley, MD Watch Slides

Best of HCV from EASL 2014

  • Best of HCV from EASL 2014 Zobair Younossi, MD, MPH, FACG Watch Slides

Best of HCV from AASLD 2013

  • Best of HCV from AASLD 2013 Michael Manns, MD Watch Slides
  • Best of HCV from AASLD 2013 Paul Kwo, MD Watch Slides
  • Best of HCV from AASLD 2013 Kimberly Brown, MD Watch Slides

2013 APASL Conference Coverage - Singapore

  • Lead in and On Treatment Response Indicators Fred Poordad, MD Watch
  • Monitoring and Stopping Rules Marc Ghany, MD Watch
  • PI Triple Therapy – Treatment of Post Liver Transplant Recipients Norah Terrault, MD,MPH Watch

HCV: Highlights From EASL 2013

  • HCV: Highlights From EASL 2013 Alex Thomspon, MBBS, PhD, FRACP Watch Slides
  • HCV: Highlights From EASL 2013 Fred Poordad, MD Watch Slides
  • HCV: Highlights From EASL 2013 Andrew J.Muir, MD Watch Slides